... screening Maternal serum screening Placental growth factor Preeclampsia (PE) is a complication affecting 2–5% of pregnancies in developed countries and up to 8% in developing countries [ 1-4 ]. PE is associated with perinatal morbidity and mortality, including fetal growth restriction, preterm...

...), with a portion (12.5%) opting to forego further screening. Women with a low probability of aneuploidy exited the model. Women who received invasive testing are at risk of procedure-related complications. Prenatal screening Maternal serum screening Noninvasive prenatal diagnosis Cost effectiveness...

... Cell-free DNA Neutrophil extracellular traps Preeclampsia Maternal serum screening Table 1 Maternal and fetal characteristics of normal pregnant women, cases with PE and nonpregnant control donors Maternal plasma and serum were collected prior to delivery or starting the CS...

... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Placental growth factor First trimester Maternal serum screening Gestational diabetes Glycosylated hemoglobin...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Maternal serum screening Pregnancy outcome l eta..l.IIl)iieaiganpoysis Fetal Diagn Ther 1996:11:249-253 ALiunbdraeyNMebiliuolnosky CUBDeonenspivttaoeernrrt...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Alpha-fetoprotein Hispanic ethnicity Maternal serum screening Neural tube...

... undergoing second-level scan due to positive triple screen with ultrasound features of PKS. Pallister-Killian syndrome Prenatal diagnosis Maternal serum screening © 2007 S. Karger AG, Basel 2007 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...

...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Undetectable unconjugated estriol Maternal serum screening Steroid sulfatase deficiency X-linked ichthyosis Fetal...

... translucency measurement (NTM) at 10–14 weeks, maternal serum screening (MSS) by α-fetoprotein (AFP) and human chorionic gonadotropin (hCG) at 15–17 weeks, and second trimester ultrasound at 21–23 weeks. Women with NTM <3 mm, MSS-derived risk <1/250, and a normal second trimester sonography were...

... the actual pattern of gene expression during pregnancy. This will also allow a more ordered and precise identification of novel prenatal diagnostic markers. Maternal serum screening Placental gene expression profile Differential display 22 6 2000 © 2000 S. Karger AG, Basel 2000...

...Owen P. Phillips; Linda Seely; Jim Y. Wan; Stephen S. Wachtel; Lee P. Shulman We asked two groups of women their opinion on prenatal diagnosis and maternal serum screening (MSS): group 1 comprised women who had undergone a prenatal diagnostic procedure (amniocentesis or chorionic villus sampling...

.... The finding of trisomy 16 confined to the placenta and FGR in 4 cases suggests that at least some fetuses with growth restriction may suffer from a distinct placental disease. Maternal serum screening may have implications different from DS and NTD, as demonstrated by the 2 cases with triploidy and incomplete...

...Lee P. Shulman; Rodney Briggs; Owen P. Phillips; Steven A. Friedman; Baha Sibai The obstetrical management of women with renal disease is complicated and associated with increased fetal and maternal morbidity. However, maternal serum screening is an integral part of obstetrical care and should...